Search for: "ACTAVIS" Results 581 - 600 of 1,006
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Dec 2018, 6:09 am by Philipp Widera
Before actually dealing with Teva, he walked the audience through Medeva, Actavis v Sanofi (C-443/12) as well as Eli Lilly v HGS (C-493/12) (both judgments issued on 12 December 2013). [read post]
12 Jul 2017, 10:14 am by Miquel Montañá
It will suffice to recall that the case stemmed from a complaint filed by Actavis against Eli Lilly in England seeking a declaration of non-infringement affecting not only England but also France, Italy and Spain. [read post]
9 Dec 2011, 2:44 am by Lawrence B. Ebert
., Obviousness Approaches of the EPO and The English Courts ), discussing Actavis v Novartis [2010] EWCA Civ 82, 17th February 2010 . [read post]
18 Jun 2013, 8:18 am by Matthew Lanahan
Actavis; the firm’s Tejinder Singh was among the counsel on an amicus brief filed by international human rights advocates in support of the respondents in Hollingsworth v. [read post]
8 Sep 2022, 12:35 pm by Zak Gowen
  The court held that plaintiffs had not met their burden of proof under Actavis to show that “the patent holder pa[id] the potential entrant to defer entry . . . [read post]
10 Dec 2010, 2:54 pm by Anna Christensen
Mensing (Granted )Docket: 09-993Issue(s): Whether the Eighth Circuit abrogated the Hatch-Waxman Amendments by allowing state tort liability for failure to warn in direct contravention of the Act’s requirement that a generic drug’s labeling be the same as the labeling approved by the Food and Drug Administration for the listed (or branded) drug.Certiorari-Stage Documents:Opinion below (8th Circuit)Petition for certiorariBrief in oppositionSupplemental brief of petitionersPetitioners'… [read post]
18 Aug 2010, 12:19 am by Kelly
(Patent Baristas) Strattera (Atomoxetine) – US: District Court rules against Lilly regarding Strattera patent: Eli Lilly v Actavis Elizabeth (GenericsWeb) Vigamox (Moxifloxacin) – US: Alcon denied permanent injunction against Teva in Vigamox litigation (Patent Docs) [read post]
12 Jul 2017, 10:14 am by Miquel Montañá
It will suffice to recall that the case stemmed from a complaint filed by Actavis against Eli Lilly in England seeking a declaration of non-infringement affecting not only England but also France, Italy and Spain. [read post]
Actavis, 570 U.S. 136 (2013), that trademark settlement agreements generally have blanket immunity from antitrust review unless the settlement agreements fall into the narrow “unusual” category defined in Actavis. [read post]
16 Aug 2011, 11:35 pm by Marie Louise
PTO does not appear to invalidate very many gene patent method claims (Holman’s Biotech IP Blog) US: Machine-or-transformation test after Myriad: Implications to the prosecution of process claims (Patent Law Practice Center) US: Unsuccessful Qui Tam plaintiff asserting false marking claim not immune from costs award: Promote Innovation v Roche Diagnostics (Docket Report) US: FDA releases two medical device draft guidances (FDA Law Blog) US: BIO: Unleashing the promise of biotechnology (pt.4)… [read post]
25 Mar 2019, 2:00 am by Matrix Legal Support Service
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
27 Jul 2009, 2:28 am
Today, when healthcare providers prescribe the cardiac drug Digoxin to a patient, [whether it will be as Lanoxin (GalaxoSmithKline) or as Digitek (Actavis Totowa)], those providers will usually monitor patient blood levels to determine the correct dosage on a case by case basis. [read post]
29 Mar 2011, 9:19 pm by Marie Louise
Navinta (Patently-O) NuvaRing (Etonogestrel, Ethinyl estradiol) – US: ITC institutes investigation (337-TA-768) regarding Certain Vaginal Ring Birth Control Devices (ITC 337 Law Blog) Nuvigil (Armodafinil) – US: Cephalon drops patent suit against Actavis over Nuvigil generic (Patent Docs) Oxycontin (Oxycodone) – US: Purdue Pharma files patent infringement suit against Watson in response to Para IV certification filing (Patent Docs) Perindopril – UK: EWHC (Pat):… [read post]
10 Jul 2017, 1:00 am by Matrix Legal Support Service
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
9 Jan 2019, 3:29 am
 IPKat's summary of the Supreme Court decision (Warner-Lambert v Actavis [2018] UKSC 56) can be found here. [read post]
14 Dec 2018, 7:55 pm by Sara Moran
Sara MoranThe Court of Appeal overturned the Patent Court’s first instance decision concerning the validity of one of ICOS’s patents (licensed to Eli Lilly) covering a 1 to 5mg dosage form of tadalafil (Cialis®) for oral administration up to a maximum of 5mg per day for the treatment of sexual dysfunction. [read post]